SCHEMBL30362841

SCHEMBL30362841

Nc1ccc(OCc2ccccc2)cn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 4/20 0.61
▸ GAA P10253 2/20 0.61
▸ MAPT P10636 1/20 0.61
▸ MAOA P21397 1/20 0.61
▸ RAB9A P51151 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ P4HTM Q9NXG6 1/20 0.58
▸ LMNA P02545 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ PTGS1 P23219 1/20 0.53
▸ SLC6A2 P23975 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ PTGS2 P35354 1/20 0.53
▸ SLC6A3 Q01959 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ HDAC6 Q9UBN7 1/20 0.53
▸ MGAM O43451 1/20 0.50
▸ SI P14410 1/20 0.50
▸ MGAM2 Q2M2H8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2648020 1.00 MAOB (0.61) MAOBGAAMAPTMAOARAB9A
Hydrochloric Acid SCHEMBL1330115 0.98 MAOB (0.59) MAOBGAAMAPTMAOARAB9A
SCHEMBL1258945 0.82 APP (0.59) MAOBMAPTRAB9ASMN1; SMN2
SCHEMBL11186146 0.82 APP (0.54) MAOBMAOARAB9ASMN1; SMN2CA12
SCHEMBL11177596 0.82 MAOB (0.59) MAOBMAOARAB9ALMNACYP1A2
SCHEMBL504815 0.81 MAOB (0.60) MAOBGAAMAPTMAOARAB9A
SCHEMBL15435397 0.81 NPC1 (0.53) MAOBMAOARAB9ALMNA
SCHEMBL13535008 0.79 P4HTM (0.60) MAOBGAAMAPTMAOARAB9A
SCHEMBL1680607 0.79 MAOB (0.59) MAOBGAAMAPTMAOARAB9A
SCHEMBL11183436 0.78 MAOB (0.67) MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118206548-A Synthesis method of [1,2,4] triazolo [1,5-a ] pyridin-6-ol 江苏工程职业技术学院 2024-06-18 — — CN claimed
US-20250034171-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2025-01-30 — — US disclosed
EP-4423097-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2024-09-04 — — EP disclosed
CN-118206548-A Synthesis method of [1,2,4] triazolo [1,5-a ] pyridin-6-ol 江苏工程职业技术学院 2024-06-18 — — CN disclosed
CN-118159543-A Imidazopyridine amides and related compounds for use in the treatment of bacterial infections 爱尔兰詹森科学公司 2024-06-07 — — CN disclosed
WO-2024089170-A1 ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2024-05-02 — — WO disclosed
WO-2023073090-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2023-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250034171-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS TPMT, QDPR, BRD4 MAOB 740/4885GAA 709/4885MAPT 1783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback